{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T18:22:38Z","timestamp":1772907758037,"version":"3.50.1"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9]]},"abstract":"<jats:p>The aim of this study was to evaluate net survival from cancer diagnosed during the period 2001\u20132010 in the north region of Portugal to identify the tumours that need actions to improve the outcomes. Data were retrieved from the North Region Cancer Registry of Portugal database. The top 20 cancer sites in adults were considered: oesophagus, stomach, colon, rectum, pancreas, liver, larynx, lung, skin melanoma, breast, cervix, corpus uteri, ovary, prostate, kidney, bladder, brain and central nervous system, thyroid, non-Hodgkin lymphoma and multiple myeloma. Net survival was estimated using the Pohar\u2013Perme estimator. The effect of diagnosis period was evaluated using flexible parametric models adjusted for age and sex where appropriate. Thyroid and prostate cancers presented the best 5-year survival (&gt;90%), whereas oesophagus, pancreas, liver and lung cancers the worst 5-year survival (&lt;20%). The largest increase in survival was observed for the larynx. A significant decrease in age-adjusted and sex-adjusted excess mortality was observed for stomach, colon, pancreas, larynx, melanoma, breast, brain and central nervous system, thyroid, non-Hodgkin lymphoma and multiple myeloma. For the other cancer sites, no significant trends were observed. For some of these sites, the downward trend in excess mortality was only observed in the short term. An important picture of population-based cancer survival outcomes for the first decade of the millennium in the north region of Portugal was presented in this study. It has been shown that improvements in survival were not universal for all cancer sites. These results should be used to highlight tumours where intervention is needed the most.<\/jats:p>","DOI":"10.1097\/cej.0000000000000378","type":"journal-article","created":{"date-parts":[[2017,6,6]],"date-time":"2017-06-06T16:36:42Z","timestamp":1496767002000},"page":"S170-S175","source":"Crossref","is-referenced-by-count":4,"title":["Survival from cancer in the north region of Portugal: results from the first decade of the millennium"],"prefix":"10.1097","volume":"26","author":[{"given":"Lu\u00eds","family":"Antunes","sequence":"first","affiliation":[{"name":"Department of Epidemiology, North Region Cancer Registry of Portugal"}]},{"given":"L\u00facio L.","family":"Santos","sequence":"additional","affiliation":[{"name":"Experimental Pathology and Therapeutics Group, IPO Porto Research Centre (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto)"}]},{"given":"Maria Jos\u00e9","family":"Bento","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, North Region Cancer Registry of Portugal"},{"name":"Unit for Multidisciplinary Research in Biomedicine (UMIB), Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, Porto, Portugal"}]}],"member":"276","reference":[{"key":"R1-20230905","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0140-6736(14)62038-9","article-title":"Global surveillance of cancer survival 1995\u20132009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2)","volume":"385","author":"Allemani","year":"2015","journal-title":"Lancet"},{"key":"R2-20230905","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2015.07.026","article-title":"Survival for oesophageal, stomach and small intestine cancers in Europe 1999\u20132007: results from EUROCARE-5","author":"Anderson","year":"2015","journal-title":"Eur J Cancer"},{"key":"R4-20230905","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2015.07.025","article-title":"Age and case mix-standardised survival for all cancer patients in Europe 1999\u20132007: results of EUROCARE-5, a population-based study","author":"Baili","year":"2015","journal-title":"Eur J Cancer"},{"key":"R5-20230905","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.canep.2015.08.004","article-title":"Performance indicators evaluation of the population-based breast cancer screening programme in Northern Portugal using the European Guidelines","volume":"39","author":"Bento","year":"2015","journal-title":"Cancer Epidemiol"},{"key":"R6-20230905","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/bjc.2013.725","article-title":"Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence","volume":"110","author":"Booth","year":"2014","journal-title":"Br J Cancer"},{"key":"R7-20230905","doi-asserted-by":"crossref","first-page":"155","DOI":"10.5301\/tj.5000542","article-title":"Trends in gastric and esophageal cancer incidence in northern Portugal (1994\u20132009) by subsite and histology, and predictions for 2015","volume":"103","author":"Castro","year":"2016","journal-title":"Tumori"},{"key":"R8-20230905","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ygyno.2014.10.023","article-title":"Ovarian cancer in the United States: contemporary patterns of care associated with improved survival","volume":"136","author":"Cliby","year":"2015","journal-title":"Gynecol Oncol"},{"key":"R9-20230905","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1016\/j.ejca.2004.07.002","article-title":"Standard cancer patient population for age standardising survival ratios","volume":"40","author":"Corazziari","year":"2004","journal-title":"Eur J Cancer"},{"key":"R10-20230905","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1470-2045(13)70546-1","article-title":"Cancer survival in Europe 1999\u20132007 by country and age: results of EUROCARE \u2013 5-a population-based study","volume":"15","author":"De Angelis","year":"2014","journal-title":"Lancet Oncol"},{"key":"R11-20230905","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/bjc.2014.217","article-title":"The impact of life tables adjusted for smoking on the socio-economic difference in net survival for laryngeal and lung cancer","volume":"111","author":"Ellis","year":"2014","journal-title":"Br J Cancer"},{"key":"R12-20230905","first-page":"193","article-title":"Innovative agents in multiple myeloma","volume":"5","author":"Faiman","year":"2014","journal-title":"J Adv Pract Oncol"},{"key":"R13-20230905","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ijsu.2013.04.004","article-title":"Three decades of clinical-pathological trends in gastric cancer: prospective data from a Portuguese hospital","volume":"11","author":"Faria","year":"2013","journal-title":"Int J Surg"},{"key":"R16-20230905","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2015.07.043","article-title":"Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: the EUROCARE-5 population-based study","author":"Gatta","year":"2015","journal-title":"Eur J Cancer"},{"key":"R17-20230905","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ygyno.2014.12.008","article-title":"Measuring ovarian cancer care: why are we still failing?","volume":"136","author":"Goff","year":"2015","journal-title":"Gynecol Oncol"},{"key":"R18-20230905","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1200\/JCO.2007.15.4088","article-title":"Clinical cancer advances 2007: major research advances in cancer treatment, prevention, and screening \u2013 a report from the American Society of Clinical Oncology","volume":"26","author":"Gralow","year":"2008","journal-title":"J Clin Oncol"},{"key":"R20-20230905","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1002\/ijc.27857","article-title":"Unbiased estimates of long-term net survival of solid cancers in France","volume":"132","author":"Jooste","year":"2013","journal-title":"Int J Cancer"},{"key":"R21-20230905","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12874-015-0057-3","article-title":"Comparison of different approaches to estimating age standardized net survival","volume":"15","author":"Lambert","year":"2015","journal-title":"BMC Med Res Methodol"},{"key":"R22-20230905","doi-asserted-by":"crossref","first-page":"e481","DOI":"10.1016\/S2352-3026(15)00155-6","article-title":"Changes in dynamics of excess mortality rates and net survival after diagnosis of follicular lymphoma or diffuse large B-cell lymphoma: comparison between European population-based data (EUROCARE-5)","volume":"2","author":"Mounier","year":"2015","journal-title":"Lancet Haematol"},{"key":"R23-20230905","doi-asserted-by":"crossref","first-page":"5486","DOI":"10.1002\/sim.3064","article-title":"Flexible parametric models for relative survival, with application in coronary heart disease","volume":"26","author":"Nelson","year":"2007","journal-title":"Stat Med"},{"key":"R24-20230905","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1541-0420.2011.01640.x","article-title":"On estimation in relative survival","volume":"68","author":"Perme","year":"2012","journal-title":"Biometrics"},{"key":"R25-20230905","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.ejca.2008.10.034","article-title":"Age-standardisation of relative survival ratios of cancer patients in a comparison between countries, genders and time periods","volume":"45","author":"Pokhrel","year":"2009","journal-title":"Eur J Cancer"},{"key":"R26-20230905","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/CEJ.0000000000000229","article-title":"Trends in thyroid cancer incidence and mortality in Portugal","volume":"26","author":"Raposo","year":"2016","journal-title":"Eur J Cancer Prev"},{"issue":"Suppl 1","key":"R27-20230905","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1038\/bjc.2015.50","article-title":"Estimating the potential survival gains by eliminating socioeconomic and sex inequalities in stage at diagnosis of melanoma","volume":"112","author":"Rutherford","year":"2015","journal-title":"Br J Cancer"},{"key":"R28-20230905","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.ejca.2008.11.018","article-title":"EUROCARE-4. Survival of cancer patients diagnosed in 1995\u20131999. Results and commentary","volume":"45","author":"Sant","year":"2009","journal-title":"Eur J Cancer"},{"key":"R31-20230905","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.canep.2016.09.011","article-title":"European code against cancer 4th edition: alcohol drinking and cancer","volume":"45","author":"Scoccianti","year":"2016","journal-title":"Cancer Epidemiol"},{"key":"R33-20230905","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1093\/annonc\/mdw408","article-title":"No \u2018cure\u2019 within 12 years of diagnosis among breast cancer patients who are diagnosed via mammographic screening: women diagnosed in the West Midlands region of England 1989\u20132011","volume":"27","author":"Woods","year":"2016","journal-title":"Ann Oncol"},{"key":"R34-20230905","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1001\/jamaoncol.2014.161","article-title":"Disparities by race, age, and sex in the improvement of survival for major cancers: results from the national cancer institute surveillance, epidemiology, and end results (SEER) program in the United States, 1990 to 2010","volume":"1","author":"Zeng","year":"2015","journal-title":"JAMA Oncol"}],"container-title":["European Journal of Cancer Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00008469-201709001-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T23:35:04Z","timestamp":1693956904000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008469-201709001-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":27,"URL":"https:\/\/doi.org\/10.1097\/cej.0000000000000378","relation":{},"ISSN":["0959-8278"],"issn-type":[{"value":"0959-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]}}}